CISPLATIN INJECTION BP
Google image searchProduct monograph
Active ingredient
cisplatin, 1 MG/ML
DIN: 02126613
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 29-NOV-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XA — Platinum compounds (ATC, ATC/DDD)
- L01XA01 — CISPLATIN (ATC/DDD)
Reference brand drug: Platinol
Pharmaceutical standard: BP
